The Valley Desk

NCT04158739 · Interventional trial

Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia

Overall registry status Active not recruiting

Phase 1

Conditions Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov